The stable ascorbic acid derivative 2-O-α-D-glucopyranosyl-L-ascorbic acid (AA-2G) was used to investigate the role of ascorbic acid (AA) 
Introduction
Cells of the immune system produce a large amount of reactive oxygen species as part of their normal functions such as chemotactic locomotion and phagocytosis. Whereas reactive oxygen species play an essential role in the intracellular killing of bacteria and other invading organisms, immune cells are sensitive to reactive oxygen species because of the high percentage of polyunsaturated fatty acids in plasma membranes of those cells [1] . A high cellular concentration of the antioxidant ascorbic acid (AA) in immune cells might contribute to the prevention of cellular damage mediated by reactive oxygen species and might have a modulatory role in the process of immune response [2] . In fact, several studies have shown in vitro and in vivo immunostimulatory effects of AA. Supplementation with AA in healthy subjects enhanced neutrophil chemotaxis and T lymphocyte proliferation [3] [4] [5] .
Administration of AA in patients exposed to toxic chemicals enhanced natural killer (NK) cell activity and improved lymphocyte blastogenic responses to T and B cell mitogens [5] [6] [7] [8] . In vitro treatment with AA was shown to stimulate phagocytosis of peritoneal macrophages and NK cell activity [9] . However, there have been few studies on the effects of AA on antibody production, and it is unknown whether or not B cell differentiation is promoted by AA. In vitro differentiation of B cells into antibody-producing plasma cells requires a culture period of several days, during which time exogenously added AA in a medium is oxidatively degraded and intracellular AA is depleted. Thus, the instability of AA in an aqueous solution is a major problem to use it in experiments of in vitro antibody production.
We have synthesized an AA derivative, 2-O-α-D-glucopyranosyl-L-ascorbic acid (AA-2G), that is stable in a solution unlike AA but is hydrolyzed by cellular α-glucosidase to release AA [10] [11] [12] [13] . In order to determine the role of AA in B cell differentiation, we investigated in this study whether AA-2G augments cytokine-dependent antibody production in in vitro anti-μ-primed B cells enriched from murine splenocytes. The results showed that AA released from AA-2G potently enhanced production of IgM by anti-μ-primed B cells through promoting the differentiation of B cells to plasma cells and attenuating a decrease in the number of viable cells.
Materials and methods

Reagents
AA-2G was donated from Hayashibara Biochemical Laboratories, Inc.
(Okayama, Japan). AA-2G was dissolved in phosphate-buffered saline, neutralized with NaOH, adjusted to 100 mM, and filtered before use. The F(ab') 2 fragment of goat anti-mouse IgM antibody (Ab) (μ chain-specific) was obtained 
Antibody response of enriched B cells stimulated with anti-μ, IL-4 and IL-5
A two-step culture system described previously was used [15, 16] . Enriched B cells were suspended in basal culture medium (RPMI 1640 medium, supplemented with 10% heat-inactivated fetal bovine serum, 2 mM L-glutamine, 100 U/mL of penicillin G and 100 μg/mL of streptomycin) and primed with anti-μ (10 μg/mL) in the presence of IL-4 (5.6 ng/mL) and IL-5 (6 ng/mL) for 2 days in flat-bottom 96-well plates (1.2 × 10 6 cells/200 μL/well) at 37 °C in an atmosphere containing 5% CO 2 . The cells were washed twice with the basal culture medium to remove anti-μ and then recultured with or without AA or AA-2G in the presence of IL-4 (5.6 ng/mL) and IL-5 (6 ng/mL) for the indicated days in triplicate in round-bottom 96-well plates at a density of 1 × 10 5 cells/200 μL/well.
The culture supernatant was then collected and was frozen at −30 °C for an IgM ELISA. The IgM levels were assayed by a sandwich ELISA essentially as described previously [17] .
Enzyme-linked immunospot (ELISPOT) assay for detection of polyclonal
IgM-secreting cells
The ELISPOT assay was performed as described previously [18] . Briefly, 
Flow cytometric analysis of cell surface antigen expression
Enriched B cells, which had been incubated with or without AA-2G for 4 days in the reculture period, were pooled and washed with and suspended in PBS containing 0.5% BSA and 0.1% sodium azide (~ 1 × 10 6 cells/100 μL). The cells were then incubated with anti-mouse CD16/CD32 mAb (10 μg/mL) for 5 min on ice and stained with FITC-conjugated anti-mouse CD45R/B220 mAb (10 μg/mL) or PE-conjugated rat anti-mouse CD138 mAb (4 μg/mL) for 30 min on ice. After being washed with and suspended in PBS containing 0.5% BSA and 0.1% sodium azide, the cells were stained with PI (2 μg/mL), and expression of CD45R/B220
and CD138 on viable cells was analyzed by a flow cytometer (Epics XL, Beckman Coulter).
Determination of apoptotic cells
Apoptotic cells were determined as described previously [19] . Briefly, 
Determination of DNA synthesis
Enriched B cells, which had been incubated with or without AA-2G for 1−4 days in the reculture period, were pulse-labeled with [ 3 H]thymidine (0.5 μCi/well, 2.5 Ci/mmol) for the last 4 h and harvested on glass fiber filters as described previously [14] . containing 10 mg/L of EDTA at a flow rate of 0.7 mL/min as described previously [20] . The absorbance at 240 nm was monitored, and the AA content was determined from the peak area of the sample with reference to the calibration by authentic AA. The intracellular AA contents are expressed as ng per 10 6 viable cells.
Determination of intracellular AA contents
Data Analysis
Results are expressed as means and S. Dunnett's T3-test. P values less than 5% were regarded as significant.
Results
Enhancement by AA-2G of IgM production by B cells stimulated with anti-μ
Murine dose-dependently increased IgM production, the greatest enhancement being 150% at concentrations of more than 0.5 mM (Fig. 1A) . IgM production was not further potentiated when AA-2G was included in both the priming period and the reculture period (data not shown). Anti-μ-primed B cells produced only a trace amount of IgM in the absence of IL-4 and IL-5 as previously reported by Phillips and Klaus [15] and Weber et al. [16] . The stimulatory effect of AA-2G was not observed in the absence of IL-4 and IL-5 (Fig. 1B) . Figure 1C shows a time course for AA-2G-induced increase in IgM production. B cells cultured without AA-2G produced a minimal amount of IgM during the initial 2 days of secondary culture but produced a significant amount of IgM thereafter. The enhancing effect of AA-2G was not observed before day 4 of secondary culture.
Enhancing effect of AA-2G mediated by released AA
AA-2G is hydrolyzed by cellular α-glucosidase to release AA [11] . To determine whether the enhancing effect of AA-2G on IgM production is mediated by AA, we employed castanospermine, an alkaloidal inhibitor of α-glucosidase [21] . Castanospermine was added to anti-μ-stimulated B cells in the second culture with AA-2G, and the cultures were incubated for 5 days. AA-2G-induced
IgM production was almost completely inhibited to the level of cultures without AA-2G by 2 μM castanospermine, which had no effect on IgM production in cultures without AA-2G ( Fig. 2A) . Changes in AA contents in cells cultured with or without AA-2G were then determined. As shown in Fig. 2B , intracellular AA contents were depleted to undetectable levels at the end of the first culture.
Addition of 0.5 mM AA-2G to the cells at the start of the second culture caused a marked increase in intracellular AA contents to more than the initial levels.
Effects of other stable AA derivatives and antioxidants on IgM production by B cells
AA-2P and AA-2S are also known as stable AA derivatives. AA-2P has been
shown to increase collagen synthesis in human fibroblasts, and it has an antiscorbutic activity in guinea pigs and monkeys, whereas AA-2S does not have either activity [22] [23] [24] . AA-2P but not AA-2S is appreciably cleaved by lysates of human dermal fibroblasts to release AA [22] . These results suggest that AA-2P
but not AA-2S is hydrolyzed by cells in culture and in vivo. Effects of both derivatives on IgM production by B cells stimulated with anti-μ, IL-4 and IL-5
were compared with the effect of AA-2G. As shown in Fig. 2C , AA-2P, but not AA-2S, increased IgM production as markedly as did AA-2G.
Effects of some antioxidants on IgM production by anti-μ-primed B cells were shown in Fig. 2D . Trolox, a cell-permeable derivative of vitamin E, glutathione and uric acid did not enhance IgM production.
Enhancement by AA-2G of differentiation of anti-μ-stimulated B cells
In order to confirm enhanced differentiation of B cells treated with AA-2G, the number of antibody-secreting cells in cultures treated with or without AA-2G for 4.5 days in the reculture period was determined by the ELISPOT assay, and the results are expressed as number of spots per reculture. Treatment with 0.5 mM AA-2G resulted in 160% increase in the number of IgM-secreting cells (Fig. 3A) .
It is known that differentiation of naive B cells to plasma cells is accompanied by
an increase in CD138 expression and by a decrease in CD45R/B220 expression [25, 26] . B cells treated with or without AA-2G for 4 days in the second culture were subjected to analyses of expression of both cell-surface antigens by a flow cytometer. AA-2G significantly increased the percent of CD138 + cells and the percent of CD45R/B220 -cells ( Fig. 3B and C) .
Attenuation by AA-2G of the decrease in viable cell number
We noticed during the ELISPOT assay in the experiments for which results are shown in Figure 3A that the viable cell number in cultures treated with AA-2G was larger than that in cultures without AA-2G: an approximately 70% increase in the former (Fig. 3A) . radical and 2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical without being hydrolyzed to AA, although the reaction of the AA derivatives with radicals is much slower than that of AA with radicals [28] [29] [30] . However, since AA-2G-promoted IgM production was almost completely inhibited by castanospermine ( Fig. 2A) and since AA-2S with a radical scavenging activity did not increase IgM production (Fig. 2C) , it seems likely that the contribution of radical-scavenging activity of AA-2G itself to AA-2G-induced augmentation of IgM production is minimal, if any.
Castanospermine is a potent competitive inhibitor of α-and β-glucosidases, but also inhibits the glycoprotein processing glucosidases glucosidase I and glucosidase II [31, 32] . Castanospermine causes the change in oligosaccharide The antioxidants Trolox, glutathione, and uric acid were ineffective in enhancing IgM production. These data suggest that the antioxidant activity is not the mechanism involved in AA-2G-induced production of IgM. However, the promoting effect of AA-2G was not observed before day 4 of secondary culture (Fig. 1C) . We cannot rule out the possibility that activities of those antioxidants was not maintained during the whole culture period.
The effect of AA-2G on differentiation of B cells was not further potentiated even when AA-2G was included in both the priming period and the reculture period. This implies that the initial AA levels present in B cells at the start of priming are high enough to elicit activity of AA if any or that AA has no important function in priming. Purified B cells contain millimolar concentrations of AA, which are much higher than those in plasma (50−150 μM), but the levels of intracellular AA decrease during cell culture [2] . The initial intracellular concentration of AA is maintained by exogenous AA added to cultures repeatedly at 12-hr intervals but not by single addition of AA because of its instability in the culture medium [2] . Single addition of AA-2G, however, is sufficient to restore and maintain the initial intracellular levels of AA for several days as shown in this study and other studies [27, 34] . Thus, AA-2G might be a useful tool for investing the physiological role of AA in long culture systems in vitro.
When a value of reported cell volume of resting mouse B cells (100 μm 3 ) is used [35] , the AA concentration in the cells at 0 h in Fig. 2B is calculated to be 2.7 mM that is not so different from the AA concentration (about 1.5 mM) in human B cells [2] . The intracellular concentration of AA is calculated to be 16 mM at 4 and 6 days after addition of AA-2G that is much greater than the initial concentration. Thus, our results suggest that antidoby production by B cells is 
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